Posts

Biopharmaceuticals Contract Manufacturing Market Size Is Expected To Reach USD 25.1 Billion By 2028

  San Francisco, 24 March 2021:   The Report  Biopharmaceuticals Contract Manufacturing Market  Size, Share & Trends Analysis Report By Source (Mammalian, Non-mammalian), By Product (Biologics, Biosimilars), By Service (Process Development), And Segment Forecasts, 2021 - 2028 The global biopharmaceuticals contract manufacturing market size is expected to reach USD 25.1 billion by 2028 registering a CAGR of 5.7%, according to a new report by Grand View Research, Inc. Growing biopharmaceutical pipeline and lack of adequate manufacturing capabilities are two key factors that are driving partnership between large molecule manufacturers and Contract Manufacturing Organizations (CMOs). Contract manufacturers are engaged in broadening their service portfolio to meet the company demands with respect to regulatory standards and new services. The reliance of companies on CMOs for the production of biologics and biosimilars is expected to rise over the forecast period as a consequence of chan

Connected Drug Delivery Devices Market Expected To Grow With USD 4.07 Billion By 2028

  San Francisco, 24 March 2021:   The Report  Connected Drug Delivery Devices Market  Size, Share & Trends Analysis Report By Technology (Bluetooth, NFC), By Product (Connected Sensors, Integrated Connected Devices), By End User, And Segment Forecasts, 2021 - 2028 The global connected drug delivery devices market size is expected to reach USD 4.07 billion by 2028 registering a CAGR of 46.7%, according to a new report by Grand View Research, Inc. Factors contributing to the growth of this market include a rise in awareness about the adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. The Covid-19 pandemic has further accentuated the need for “contactless” services, thereby increasing the demand for connected drug delivery devices as well as providing lucrative growth opportunities in the coming years. Connected drug delivery devices help physicians to monitor the compliance of patients to the therapy prescribed by them

Endoscopes Market Size To Hit USD 19.4 Billion By 2028

  San Francisco, 24 March 2021:   The Report  Endoscopes Market  Size, Share & Trends Analysis Report By Product (Flexible Endoscopes, Disposable Endoscopes), By Application, By End-use, By Region, And Segment Forecasts, 2021 - 2028 The global endoscopes market size is expected to reach USD 19.4 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.0% from 2021 to 2028. The growing awareness regarding the benefits of minimally invasive surgeries as compared to open invasive surgeries and the rising prevalence of chronic diseases, such as cancer, heart diseases, and diabetes, are some of the factors driving the market. In addition, technological advancements with respect to endoscopes and the increasing applications in various diagnosis and treatment processes are among the key trends boosting the demand for endoscopes globally. Based on product, flexible endoscopes dominated the market with a share of 49.9% in 2020. This is

Image-guided Therapy Systems Market Is Expected To Reach $ 5.8 Billion By 2028

  San Francisco, 24 March 2021:   The Report  Image-guided Therapy Systems Market  Size, Share & Trends Analysis Report By Product (Endoscopes, MRI), By Application (Cardiac Surgery, Neurosurgery), By End-use (Hospitals, ASCs), And Segment Forecasts, 2021 - 2028 The global image-guided therapy systems market size is expected to reach USD 5.8 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.0% from 2021 to 2028. The growing geriatric population base and increasing cases of chronic diseases are expected to boost the market growth. Other factors propelling the market growth include a rising preference for minimally invasive surgeries and technological advancements in image-guided therapy systems. Various initiatives undertaken in the area of cancer radiotherapy are also driving the market. New product launches by major companies are also having a positive impact on market growth. For instance, in September 2020, Olympus Co

Drug Discovery Informatics Market Size Poised To Reach USD 5.63 Billion By 2028

  San Francisco, 24 March 2021:   The Report  Drug Discovery Informatics Market  Size, Share & Trends Analysis Report By Mode (In-house, Outsourced), By Workflow (Discovery, Development), By Services (Sequence Analysis Platforms, Docking), And Segment Forecasts, 2021 - 2028 The global drug discovery informatics market size is expected to reach USD 5.63 billion by 2028 registering a CAGR of 11.3% over the forecast period, according to a new report by Grand View Research, Inc. Use of drug discovery software for gaining market intelligence owing to several advantages, such as rapid drug design & synthesis, efficient tracking of disease evolution, and data integrity management, has increased significantly among the researchers in the recent years, driving the industry growth. The growing demand for novel molecules is driving the adoption of informatics solutions targeted towards speeding up the entire drug discovery process by identifying rational drug molecules via the target macr

Genomics Market Exhibiting At A CAGR Of 15.35%From 2021 To 2028

  San Francisco, 23 March 2021:   The Report  Genomics Market  Size, Share & Trends Analysis Report By Application & Technology (Functional Genomics, Pathway Analysis), By Deliverable (Products, Services), By End-use, By Region, And Segment Forecasts, 2021 - 2028 The global genomics market size is expected to reach USD 62.9 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.35% from 2021 to 2028. A rise in the demand for the solutions to catalog vast genomic information into a usable form and to utilize it in clinical workflows is expected to drive the market. This has also led to an increase in the market competition, coupled with the development of breakthrough genomic technologies by Veritas Genetics, 23andMe, and other key players. In August 2020, Ancestry launched a new next-generation sequencing-based tool to screen genes linked to blood disorders, colon cancer, heart diseases, and breast cancer. This product,

Blood Pressure Monitoring Devices Market To Exhibit A Lucrative CAGR Of 11.2%From 2021 to 2028

  San Francisco, 23 March 2021:   The Report  Blood Pressure Monitoring Devices Market  Size, Share & Trends Analysis Report By Product (Sphygmomanometers/Aneroid BP Monitors, Ambulatory BP Monitors), By End-use, By Region, And Segment Forecasts, 2021 - 2028 The global blood pressure monitoring devices market size is expected to reach USD 3.24 billion by 2028, according to a new report by Grand View Research. It is expected to expand at a CAGR of 11.2% from 2021 to 2028. The growing geriatric population across the globe is expected to widen the target consumers by triggering incidence rates of hypertension, which is expected to drive the demand for blood pressure monitoring devices. The increasing incidence of hypertension has led to rising demand for cost-effective, rapid, and accurate diagnostic solutions. Blood pressure monitors are one of the vital signs monitors of life. The cost-effective and accurate results offered by these indicators are one of the key factors responsible